Clinical Trial Update: A Trial Using CD133 Enriched Bone Marrow Cells Following Primary Angioplasty for Acute Myocardial Infarction [NA]

View source ↗

Summary

The trial evaluated using CD133-enriched bone marrow cells after primary angioplasty in patients with acute myocardial infarction; the study status is terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• CD133 Enriched Bone Marrow Cells

Snippet

Sponsor: Jozef Bartunek | Conditions: Acute Myocardial Infarction | NA | Status: TERMINATED